Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CIMILRE Free-T2 Plus

K-Number: K221708 · 2022-12-23

Decision Date2022-12-23
Product CodeHGX
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

CIMILRE Free-T2 Plus is a medical device manufactured by Cimilre Co., Ltd.. It received FDA 510(k) clearance on 2022-12-23 under approval number K221708. The device is classified under product code HGX. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CIMILRE Free-T2 Plus?

CIMILRE Free-T2 Plus is a medical device that received FDA 510(k) clearance on 2022-12-23. It is manufactured by Cimilre Co., Ltd.. The 510(k) number is K221708.

When was CIMILRE Free-T2 Plus approved by the FDA?

CIMILRE Free-T2 Plus received FDA 510(k) clearance on 2022-12-23, under approval number K221708.

What company makes CIMILRE Free-T2 Plus?

CIMILRE Free-T2 Plus is manufactured by Cimilre Co., Ltd..

What is the FDA product code for CIMILRE Free-T2 Plus?

The FDA product code for CIMILRE Free-T2 Plus is HGX.

Other Devices by Cimilre Co., Ltd.

Related Devices (Code: HGX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.